Hall Zach W
Regen Med. 2007 Jan;2(1):25-8. doi: 10.2217/17460751.2.1.25.
The California Institute for Regenerative Medicine (CIRM) was established in 2004 with the passage of Proposition 71, the California Stem Cell Research and Cures Initiative. The statewide ballot measure, which provided US$3 billion in funding for stem cell research at California universities and research institutions, was approved by California voters, and called for the establishment of an entity to make grants and provide loans for stem cell research, research facilities and other vital research opportunities. Here, Dr Zach Hall, Interim President of the CIRM, outlines the ethos and aspirations of the CIRM to Regenerative Medicine. Dr Hall trained as a basic neuroscientist and became a faculty member and department chair at the University of California, San Francisco. In 1994, he was appointed Director of National Institute of Neurological Disorders and Stroke within the National Institutes of Health, and was responsible for a research program that awarded more than US$500 million a year in grants and contracts. Since that time, he has held senior positions in research administration within both the University of California, San Francisco, where he was Executive Vice Chancellor, and the University of Southern California. Full information about the CIRM can be found at www.cirm.ca.gov.
加利福尼亚再生医学研究所（CIRM）于2004年随着第71号提案的通过而成立，该提案即《加利福尼亚干细胞研究与治疗倡议》。这项全州范围的投票措施为加利福尼亚的大学和研究机构的干细胞研究提供了30亿美元的资金，获得了加利福尼亚选民的批准，并要求成立一个实体，为干细胞研究、研究设施及其他重要研究机会提供资助和贷款。在此，CIRM临时主席扎克·霍尔博士概述了CIRM对再生医学的理念和期望。霍尔博士最初是一名基础神经科学家，后来成为加利福尼亚大学旧金山分校的教员和系主任。1994年，他被任命为国立卫生研究院下属的国立神经疾病与中风研究所所长，负责一个每年授予超过5亿美元资助和合同的研究项目。从那时起，他在加利福尼亚大学旧金山分校（他曾担任执行副校长）和南加利福尼亚大学担任研究管理方面的高级职位。有关CIRM的完整信息可在www.cirm.ca.gov上查询。
